Free CME from PeerView


Oncology CME

Credits: 0.25 CME / MOC
Medical Learning Institute, Inc.
Practice Points in TGCT: Updates on Safe Use of Novel Systemic Options
January 13, 2022
Melissa Hohos, RN, BSN, OCN
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
January 13, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors
December 31, 2021
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
December 29, 2021
Credits: 2 CME
Penn State College of Medicine
Achieving Innovation in CLL Care: Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management
December 29, 2021
Credits: 0.5 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy
December 27, 2021
Jacqueline Barrientos, MD, MS
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management
December 10, 2021
Noa Biran, MD
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
A Is for Antibody in Multiple Myeloma: Practical Insights and Patient Voices Along the Therapeutic Journey
December 10, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Taking the Turn to Treatment Innovation in DLBCL: Real-World Insight on Integrating Antibodies and Cellular Therapy Into Patient Care
December 10, 2021
Credits: 1.5 CME
Medical Learning Institute, Inc.
A Better Blend for Follicular Lymphoma: How Targeted, Epigenetic, and Immune Therapies Are Changing Patient Care
December 10, 2021
Credits: 2 CME / MOC
Medical Learning Institute, Inc.
Seizing Opportunity in AML: How to Realize the Potential of Novel Therapeutics in Diverse Patient Populations
December 9, 2021
Pedro C. Barata, MD, MSc
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
November 30, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies
November 30, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing Tides in Advanced Endometrial Cancer: A Visual Exploration of Current and Emerging Strategies to Maximize the Potential of Cancer Immunotherapies
November 29, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Noncovalent Options
November 18, 2021
Credits: 1 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Improving the Detection and Management of Cardiac Immune-Related Adverse Events in Patients With Cancer Is a Must: Are You Prepared?
November 14, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Harmonizing HCC Care With a Multidisciplinary Ensemble: Guidance for the Era of Novel Locoregional, Multimodal, and Systemic Strategies
November 13, 2021
Credits: 1 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar in HR+/HER2- Early Breast Cancer: Multidisciplinary Strategies for Integrating the CDK4 and 6 Inhibitors
November 7, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Maintaining Vigilance to Mitigate Cancer Immunotherapy-Related Toxicities in the Emergency Department: Be Aware, Stay Alert, and Change Your Practice
October 24, 2021

Pages